The Food and Drug Administration approved or tentatively approved a record 126 generic drugs in July, the agency reported Thursday, an indication that Republicans are getting the faster approvals they have sought.

The agency approved 96 generic drugs and gave a tentative approval to 30 more in July, according to monthly data. Greater generic competition with pricier brand-name drugs is often thought to be a critical factor in improving drug prices.

Recommended Stories

White House credits Trump deregulation for $26 billion in drug savings

FDA approves first generic competitor for EpiPen

FDA chief criticizes health insurers, drug plans for ‘shell games’ over pricing